Article

Quantifiable data suggest vision loss should be given priority

"The distribution and causes of vision loss today are vastly different from 100 years ago when Edward Jackson was in practice."

"The distribution and causes of vision loss today are vastly different from 100 years ago when Edward Jackson was in practice."

Hugh R. Taylor, AC, MD, made the comparison in his presentation "Eye Care: Dollars and Sense," the 63rd Jackson Memorial Lecture, given during the opening session of the 2006 American Academy of Ophthalmology annual meeting.

However, Dr. Taylor continued, the key difference between then and now is the data set on vision impairment created by Dr. Taylor and his colleagues. Significant investments were made in tracking and quantifying visual impairment in Australia. The results were so consistent with other developed countries that the data set can be applied globally.

"Health planners and policy makers need to take vision loss seriously, give vision loss priority," Dr. Taylor said. "The time to act is now. To prevent avoidable vision loss, we must prevent diseases we can prevent, treat diseases we can treat, and substantially increase research funding."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.